Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection
出版年份 2021 全文链接
标题
Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection
作者
关键词
-
出版物
Viruses-Basel
Volume 13, Issue 11, Pages 2132
出版商
MDPI AG
发表日期
2021-10-26
DOI
10.3390/v13112132
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- SARS-CoV-2 infects cells following viral entry via clathrin-mediated endocytosis
- (2021) Armin Bayati et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target
- (2021) Gillina F. G. Bezemer et al. Frontiers in Pharmacology
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro
- (2021) Finny Varghese et al. Viruses-Basel
- SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development
- (2021) Nicholas Murgolo et al. PLoS Pathogens
- Cell Surface Expression of Endosomal Toll-Like Receptors—A Necessity or a Superfluous Duplication?
- (2021) Matylda Barbara Mielcarska et al. Frontiers in Immunology
- SARS-CoV-2 spike protein interacts with and activates TLR41
- (2021) Yingchi Zhao et al. CELL RESEARCH
- TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines
- (2021) Min Zheng et al. NATURE IMMUNOLOGY
- SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes
- (2021) Yize Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA
- (2021) Jasmine Cubuk et al. Nature Communications
- COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
- (2021) Robert W. Malone et al. Frontiers in Pharmacology
- Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection
- (2021) Rukmini Mukherjee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SARS-CoV-2 takes its Toll
- (2021) Alan Sariol et al. NATURE IMMUNOLOGY
- Localization of SARS-CoV-2 Capping Enzymes Revealed by an Antibody against the nsp10 Subunit
- (2021) Vladimira Horova et al. Viruses-Basel
- Correlative multi-scale cryo-imaging unveils SARS-CoV-2 assembly and egress
- (2021) Luiza Mendonça et al. Nature Communications
- Middle East respiratory syndrome coronavirus – The need for global proactive surveillance, sequencing and modeling
- (2021) Jaffar A. Al-Tawfiq et al. Travel Medicine and Infectious Disease
- SARS-CoV-2–associated ssRNAs activate inflammation and immunity via TLR7/8
- (2021) Valentina Salvi et al. JCI Insight
- TLR3 and TLR7 RNA Sensor Activation during SARS-COV-2 Infection
- (2021) Daria Bortolotti et al. Microorganisms
- Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
- (2020) Aiping Wu et al. Cell Host & Microbe
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
- (2020) Clark D Russell et al. LANCET
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses
- (2020) Furong Qi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
- (2020) Carly G.K. Ziegler et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Identification of a novel coronavirus causing severe pneumonia in human
- (2020) Li-Li Ren et al. CHINESE MEDICAL JOURNAL
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity
- (2020) Virgil Schijns et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs
- (2020) Abhigyan Choudhury et al. JOURNAL OF MEDICAL VIROLOGY
- A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
- (2020) Markus Hoffmann et al. MOLECULAR CELL
- Structure of replicating SARS-CoV-2 polymerase
- (2020) Hauke S. Hillen et al. NATURE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
- (2020) Xin Zou et al. Frontiers of Medicine
- Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
- (2020) Sisi Kang et al. Acta Pharmaceutica Sinica B
- Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
- (2020) Alessio Mazzoni et al. JOURNAL OF CLINICAL INVESTIGATION
- Intra-genome variability in the dinucleotide composition of SARS-CoV-2
- (2020) Paul Digard et al. Virus Evolution
- The coding capacity of SARS-CoV-2
- (2020) Yaara Finkel et al. NATURE
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- Mechanisms of SARS-CoV-2 transmission and pathogenesis
- (2020) Andrew G. Harrison et al. TRENDS IN IMMUNOLOGY
- The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
- (2020) Hamid Reza Samimagham et al. Trials
- Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19
- (2020) Jang Hyun Park et al. Frontiers in Immunology
- Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
- (2020) Rajendra Karki et al. CELL
- β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway
- (2020) Sourish Ghosh et al. CELL
- SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography
- (2020) Steffen Klein et al. Nature Communications
- Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection
- (2020) Pranesh Padmanabhan et al. PLoS Computational Biology
- The protective effect of the anti-Toll-like receptor 9 antibody against acute cytokine storm caused by immunostimulatory DNA
- (2017) Yusuke Murakami et al. Scientific Reports
- Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4
- (2016) X Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- TLR10 Is a B Cell Intrinsic Suppressor of Adaptive Immune Responses
- (2016) Nicholas J. Hess et al. JOURNAL OF IMMUNOLOGY
- Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases
- (2015) Atsuo Kanno et al. Nature Communications
- Role of berberine in anti-bacterial as a high-affinity LPS antagonist binding to TLR4/MD-2 receptor
- (2014) Ming Chu et al. BMC Complementary and Alternative Medicine
- Roles of the Cleaved N-Terminal TLR3 Fragment and Cell Surface TLR3 in Double-Stranded RNA Sensing
- (2014) Yusuke Murakami et al. JOURNAL OF IMMUNOLOGY
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- Primary blood neutrophils express a functional cell surface Toll-like receptor 9
- (2013) Dennis Lindau et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Toll-Like Receptor Expression and Induction of Type I and Type III Interferons in Primary Airway Epithelial Cells
- (2013) I. Ioannidis et al. JOURNAL OF VIROLOGY
- An essential role for the N-terminal fragment of Toll-like receptor 9 in DNA sensing
- (2013) Masahiro Onji et al. Nature Communications
- A Human Coronavirus Responsible for the Common Cold Massively Kills Dendritic Cells but Not Monocytes
- (2012) M. Mesel-Lemoine et al. JOURNAL OF VIROLOGY
- Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response
- (2012) Yan Li et al. MICROBES AND INFECTION
- The Role of TLR2 in Infection and Immunity
- (2012) Laura Oliveira-Nascimento et al. Frontiers in Immunology
- Intracellular Toll-like Receptors
- (2010) Amanda L. Blasius et al. IMMUNITY
- Circulating mitochondrial DAMPs cause inflammatory responses to injury
- (2010) Qin Zhang et al. NATURE
- Recognition of Lipopeptide Patterns by Toll-like Receptor 2-Toll-like Receptor 6 Heterodimer
- (2009) Jin Young Kang et al. IMMUNITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started